Facebook
Twitter
Telegram
Report an ErrorBioCryst Pharmaceuticals Balance Sheet 2011-2024 | BCRX
Annual Balance Sheet BioCryst Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
194 M | -71.6 M | -204 M | -150 M | -34.3 M | 32.3 M | 1.61 M | 28.9 M | 3.48 M | -24.5 M | 25.7 M | 23.8 M | 38.8 M |
Long Term Debt |
303 M | 232 M | 298 M | 123 M | 41.3 M | 25.4 M | 16.8 M | 22.8 M | - | - | 30 M | 30 M | 30 M |
Long Term Debt Current |
1.06 M | 1.52 M | 1.82 M | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 44.7 M | 28.1 M | 19.7 M | 33.9 M | 12.4 M | 3.55 M | 34.7 M | 40.7 M | 41.1 M |
Total Current Liabilities |
150 M | 106 M | 104 M | 106 M | 92.3 M | 69.5 M | 74.8 M | 54.4 M | 64.5 M | 57.7 M | 15.3 M | 17.2 M | 26.3 M |
Total Liabilities |
- | - | - | - | 137 M | 97.6 M | 94.5 M | 88.3 M | 76.8 M | 61.2 M | 50 M | 57.9 M | 67.4 M |
Deferred Revenue |
- | 1.22 M | 1.42 M | 150 K | 2.12 M | 221 K | 8.48 M | 2.02 M | 2.16 M | 7.09 M | 1.47 M | 1.39 M | 9.79 M |
Retained Earnings |
-1.68 B | -1.45 B | -1.21 B | -1.02 B | -841 M | -732 M | -632 M | -566 M | -511 M | -468 M | -423 M | -393 M | -354 M |
Total Assets |
517 M | 550 M | 588 M | 335 M | 175 M | 147 M | 178 M | 89.8 M | 125 M | 137 M | 48.9 M | 57.4 M | 82.2 M |
Cash and Cash Equivalents |
111 M | 305 M | 504 M | 272 M | 114 M | 26.7 M | 50.3 M | 22.1 M | 28.9 M | 54.5 M | 21.2 M | 20.9 M | 16.4 M |
Book Value |
517 M | 550 M | 588 M | 335 M | 38.3 M | 49.2 M | 83.8 M | 1.58 M | 47.7 M | 75.6 M | -1.13 M | -454 K | 14.8 M |
Total Shareholders Equity |
-456 M | -295 M | -107 M | -19.3 M | 38.3 M | 49.2 M | 83.8 M | 1.58 M | 47.7 M | 75.6 M | -1.13 M | -454 K | 14.8 M |
All numbers in USD currency
Quarterly Balance Sheet BioCryst Pharmaceuticals
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
308 M | 303 M | 298 M | 293 M | 233 M | 232 M | 224 M | - | 140 M | 136 M | 132 M | 127 M | 123 M | 120 M | 120 M | 120 M | 120 M | - | 50 M | 50 M | 50 M | 30 M | 30 M | 19.6 M | 21.3 M | 23 M | 23 M | 23 M | 23 M | 23 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | 522 K | 1.78 M | 1.2 M | 1.22 M | 1.55 M | - | 1.47 M | 1.42 M | 602 K | 551 K | 405 K | 150 K | 150 K | 150 K | 150 K | 2.12 M | 2.12 M | 2.12 M | 2.12 M | 221 K | 221 K | 221 K | 221 K | 8.48 M | 8.48 M | 8.48 M | 8.48 M | 2.02 M | 2.02 M | 2.02 M | 2.02 M | 2.16 M | 2.16 M | 2.16 M | - | - | 1.48 M | 1.48 M | 1.47 M | 1.47 M | 1.54 M | 1.47 M | 1.47 M | 1.39 M | 1.39 M | 1.39 M | 1.39 M | 9.79 M | 9.79 M | 9.79 M | 9.79 M |
Retained Earnings |
-1.72 B | -1.68 B | -1.62 B | -1.58 B | -1.51 B | -1.45 B | -1.38 B | - | -1.28 B | -1.21 B | -1.19 B | -1.13 B | -1.09 B | -1.02 B | -1.02 B | -1.02 B | -1.02 B | -841 M | -841 M | -841 M | -841 M | -732 M | -732 M | -732 M | -732 M | -632 M | -632 M | -632 M | -632 M | -566 M | -566 M | -566 M | -566 M | -511 M | -511 M | -511 M | -511 M | -468 M | -468 M | -468 M | -468 M | -423 M | -423 M | -423 M | -423 M | -393 M | -393 M | -393 M | -393 M | -354 M | -354 M | -354 M | -354 M |
Total Assets |
468 M | 517 M | 523 M | 530 M | 510 M | 550 M | 559 M | - | 528 M | 588 M | 266 M | 277 M | 284 M | 335 M | 335 M | 335 M | 335 M | 175 M | 175 M | 175 M | 175 M | 147 M | 147 M | 147 M | 147 M | 178 M | 178 M | 178 M | 178 M | 89.8 M | 89.8 M | 89.8 M | 89.8 M | 122 M | 122 M | 122 M | 122 M | 137 M | 137 M | 137 M | 137 M | 48.9 M | 48.9 M | 48.9 M | 48.9 M | 57.4 M | 57.4 M | 57.4 M | 57.4 M | 82.2 M | 82.2 M | 82.2 M | 82.2 M |
Cash and Cash Equivalents |
84.3 M | 111 M | 151 M | 146 M | 155 M | 305 M | 247 M | - | 396 M | 504 M | 200 M | 210 M | 227 M | 272 M | 272 M | 272 M | 272 M | 114 M | 114 M | 114 M | 114 M | 26.7 M | 26.7 M | 26.7 M | 26.7 M | 50.3 M | 50.3 M | 50.3 M | 50.3 M | 22.1 M | 22.1 M | 22.1 M | 22.1 M | 28.9 M | 28.9 M | 28.9 M | 28.9 M | 54.5 M | 54.5 M | 54.5 M | 54.5 M | 21.2 M | 21.2 M | 21.2 M | 21.2 M | 20.9 M | 20.9 M | 20.9 M | 20.9 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M |
Book Value |
468 M | 517 M | 523 M | 530 M | 510 M | 550 M | 559 M | - | 528 M | 588 M | 266 M | 277 M | 284 M | 335 M | 335 M | 335 M | 335 M | 175 M | 175 M | 175 M | 175 M | 147 M | 147 M | 147 M | 147 M | 178 M | 178 M | 178 M | 178 M | 89.8 M | 89.8 M | 89.8 M | 89.8 M | 122 M | 122 M | 122 M | 122 M | 137 M | 137 M | 137 M | 137 M | 48.9 M | 48.9 M | 48.9 M | 48.9 M | 57.4 M | 57.4 M | 57.4 M | 57.4 M | 82.2 M | 82.2 M | 82.2 M | 82.2 M |
Total Shareholders Equity |
-476 M | -456 M | -411 M | -389 M | -328 M | -295 M | -243 M | -213 M | -164 M | -107 M | -147 M | -106 M | -75 M | -19.3 M | -19.3 M | -19.3 M | -19.3 M | 38.3 M | 38.3 M | 38.3 M | 38.3 M | 49.2 M | 49.2 M | 49.2 M | 49.2 M | 83.8 M | 83.8 M | 83.8 M | 83.8 M | 1.58 M | 1.58 M | 1.58 M | 1.58 M | 47.7 M | 47.7 M | 47.7 M | 47.7 M | 75.6 M | 75.6 M | 75.6 M | 75.6 M | -1.13 M | -1.13 M | -1.13 M | -1.13 M | -454 K | -454 K | -454 K | -454 K | 14.8 M | 14.8 M | 14.8 M | 14.8 M |
All numbers in USD currency